NL
AZN icon

NWAM LLC’s AstraZeneca AZN Stock Holding History

NWAM LLC’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$656K Sell
3,458
-815
-19% -$153K 0.03% 391
2026
Q1 		$843K Sell
4,273
-61
-1% -$11.8K 0.05% 317
2025
Q4 		$815K Hold
4,334
– – 0.05% 309
2025
Q3 		$723K Buy
4,334
+816
+23% +$124K 0.04% 340
2025
Q2 		$513K Sell
3,518
-2,360
-40% -$331K 0.03% 388
2025
Q1 		$864K Buy
5,878
+1,854
+46% +$268K 0.07% 230
2024
Q4 		$527K Hold
4,024
– – 0.03% 367
2024
Q3 		$627K Buy
+4,024
New +$650K 0.04% 339
2024
Q2 		– Sell
-3,545
Closed -$536K – 183
2024
Q1 		$536K Sell
3,545
-452
-11% -$59.9K 0.04% 319
2023
Q4 		$535K Sell
3,997
-49
-1% -$6.37K 0.04% 330
2023
Q3 		$548K Buy
4,046
+133
+3% +$18.2K 0.06% 278
2023
Q2 		$560K Sell
3,913
-14
-0.4% -$2.06K 0.05% 313
2023
Q1 		$545K Sell
3,927
-100
-2% -$13.5K 0.06% 259
2022
Q4 		$546K Buy
4,027
+284
+8% +$35.6K 0.05% 301
2022
Q3 		$411K Buy
3,743
+149
+4% +$18.9K 0.04% 329
2022
Q2 		$471K Sell
3,594
-1,371
-28% -$180K 0.04% 311
2022
Q1 		$659K Buy
4,965
+1,655
+50% +$198K 0.05% 278
2021
Q4 		$386K Buy
3,310
+1,546
+88% +$182K 0.03% 370
2021
Q3 		$212K Buy
+1,764
New +$205K 0.02% 462

Other funds holding AZN

EP
Evelyn Partners London $46.9B AUM
IA
Investor AB Stockholm, Sweden $14.4B AUM 4.07% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $480B AUM 42.84% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

NWAM LLC's AZN Position: Q2 2026 in Review

NWAM LLC reduced its AstraZeneca (AZN) stake by 19% in Q2 2026, selling an estimated $153K and leaving 3,458 shares worth $656K. The position accounts for 0.03% of the portfolio, ranked #391.

NWAM LLC first reported a position in AZN in Q3 2021 and has held it in 19 quarters since. The position peaked at $864K in Q1 2025. 1,495 funds tracked by Wall St. Rank hold AZN as of Q2 2026.

  • NWAM LLC held 3,458 shares of AstraZeneca worth $656K as of Q2 2026.
  • NWAM LLC sold 815 AstraZeneca shares in Q2 2026, an estimated $153K.
  • AstraZeneca made up 0.03% of NWAM LLC's portfolio in Q2 2026, its #391 holding.
  • NWAM LLC first reported a position in AstraZeneca in Q3 2021 and has held it in 19 quarters since.
  • NWAM LLC's AstraZeneca position peaked at $864K in Q1 2025.
  • 1,495 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.

Based on NWAM LLC's 13F filing for Q2 2026, filed 23 Jul 2026.